Related Experiment Video
Updated: Aug 2, 2025

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023
The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022
Paolo A Ascierto1, Renier Brentjens2, Samir N Khleif3
1Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy. paolo.ascierto@gmail.com.
Leading experts debated key immunotherapy topics, including adoptive cell therapy for solid tumors and biomarker strategies. Audience votes reflected engagement with diverse expert viewpoints on cutting-edge cancer treatments.
Area of Science:
- Immunotherapy research and clinical applications.
Background:
- The 2022 Immunotherapy Bridge congress hosted a Great Debate session.
- This session addressed contemporary challenges and advancements in immunotherapy.
Purpose of the Study:
- To present and discuss contrasting expert opinions on critical immunotherapy topics.
- To gauge audience perception and shifts in opinion regarding these topics.
Main Methods:
- Three distinct debates were conducted, featuring leading experts presenting counterpoint views.
- Topics included the role of adoptive cell therapy (ACT) in solid tumors.
- Debates also covered peripheral/blood biomarkers versus tumor microenvironment biomarkers for cancer immunotherapy, and chimeric antigen receptor T cell versus natural killer cell therapy.
Main Results:
- Expert opinions were presented on the utility of ACT in solid tumors.
- The relative merits of peripheral/blood biomarkers versus tumor microenvironment biomarkers were debated.
- The comparative roles of chimeric antigen receptor T cell therapy and natural killer cell therapy were discussed.
Conclusions:
- The debates stimulated discussion on the evolving landscape of cancer immunotherapy.
- Audience voting before and after each debate provided insights into evolving perspectives on these complex issues.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Psychoneuroimmunology: Diabetes and Cancer

